BioNTech SE (BNTX)
113.08
+1.74
(+1.56%)
USD |
NASDAQ |
Dec 20, 16:00
114.20
+1.12
(+0.99%)
After-Hours: 20:00
BioNTech Profit Margin (Quarterly): 15.91% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Edap TMS SA | -48.85% |
| Pfizer Inc | 25.22% |
| Trinity Biotech PLC | -31.41% |
| Akari Therapeutics PLC | -- |
| Moderna Inc | 0.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.35% |
| Return on Assets | -2.06% |
| Return on Invested Capital | -2.32% |
| Gross Profit Margin (Quarterly) | 85.63% |
| Operating Margin (Quarterly) | 0.84% |
| Return on Net Operating Assets | -10.80% |